0001104659-19-022379.txt : 20190418
0001104659-19-022379.hdr.sgml : 20190418
20190418171301
ACCESSION NUMBER: 0001104659-19-022379
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190416
FILED AS OF DATE: 20190418
DATE AS OF CHANGE: 20190418
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Buchholz Richard
CENTRAL INDEX KEY: 0001737133
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38468
FILM NUMBER: 19756607
MAIL ADDRESS:
STREET 1: C/O INSPIRE MEDICAL SYSTEMS, INC.
STREET 2: 9700 63RD AVENUE NORTH, SUITE 200
CITY: MAPLE GROVE
STATE: MN
ZIP: 55369
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inspire Medical Systems, Inc.
CENTRAL INDEX KEY: 0001609550
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 261377674
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5500 WAYZATA BLVD
STREET 2: SUITE 1600
CITY: GOLDEN VALLEY
STATE: MN
ZIP: 55416
BUSINESS PHONE: 763-957-5037
MAIL ADDRESS:
STREET 1: 5500 WAYZATA BLVD
STREET 2: SUITE 1600
CITY: GOLDEN VALLEY
STATE: MN
ZIP: 55416
4
1
a4.xml
4
X0306
4
2019-04-16
0
0001609550
Inspire Medical Systems, Inc.
INSP
0001737133
Buchholz Richard
C/O INSPIRE MEDICAL SYSTEMS, INC.
5500 WAYZATA BLVD., SUITE 1600
GOLDEN VALLEY
MN
55416
0
1
0
0
Chief Financial Officer
Common Stock
2019-04-16
4
M
0
4000
2.07
A
8750
D
Common Stock
2019-04-16
4
S
0
1974
55.59
D
6776
D
Common Stock
2019-04-16
4
S
0
2026
56.50
D
4750
D
Stock Option (Right to Buy)
2.07
2019-04-16
4
M
0
4000
0
D
2024-05-31
Common Stock
4000
68706
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.28 to $56.22. The Reporting Person undertakes to provide the Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.30 to $56.73. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option is fully vested and exercisable.
/s/ Richard Buchholz
2019-04-18